Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-016069
Filing Date
2013-03-11
Accepted
2013-03-11 17:36:05
Documents
1
Period of Report
2013-03-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rrd373155.html 4  
1 PRIMARY DOCUMENT rrd373155.xml 4 5804
  Complete submission text file 0001181431-13-016069.txt   7530
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SCICLONE PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404-2125
Business Address
Titus Gary (Reporting) CIK: 0001298900 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35560 | Film No.: 13681928